Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria
Uneke, CJ, Ogbu, O, Inyama, PU, Anyanwu, GI, Njoku, MO, Idoko, JH
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
Information is very scarce on the prevalence of hepatitis-B virus (HBV) infection among blood donors and patients with human immunodeficiency virus (HIV) infection in Nigeria. Hepatitis-B surface antigen (HBsAg) ELISA was used to determined the prevalence of HBsAg among 175 blood donors (aged 20-40 years) and 490 HIV-infected patients (aged 17-60 years) in Jos, Nigeria. Twenty-five (14.3%) of the blood donors and 127 (25.9%) of the HIV-infected individuals were HBsAg seropositive, indicating a higher HBV infection among HIV-infected persons than among healthy blood donors. A slightly higher HBsAg seroprevalence was recorded in the males (14.6%) than females (12.9%) of the blood donors. Among the HIV-infected patients, the males had considerably higher HBsAg seroprevalence than the females (31.8 vs 22.1%) with the highest prevalence of HBsAg occurring in the 51-60 years age group (44%), followed by those of 31-40 years (28.2%). Results confirmed the high endemicity of HBV infection in Jos, Nigeria and the significantly greater prevalence of HBV infection among HIV -infected patients than among blood donors.
- Hepatitis-B virus infection in sexually transmitted disease clinic attenders in an African city, (Jos, Nigeria)
- Hepatitis-B surface antigen and antibody in Black and White patients with venereal diseases.
- Hepatitis B Virus DNA in Sera of Blood Donors and of Patients Infected with Hepatitis C Virus and Human Immunodeficiency Virus
- Parvovirus B19 seroconversion in a cohort of human immunodeficiency virus-infected patients
- Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Individuals